ACTIONABILITY KNOWLEDGE REPOSITORY ACTIONABILITY CURATION INTERFACE
Update History
Syndrome: Tuberous Sclerosis Complex (TSC)
Gene/Gene Panel: TSC1, TSC2
Context: Adult
Date
Status
Outcomes-Interventions
Notes
2020/04/29
Released
1.1.2
LAM development in women (GroupA)
mTOR inhibitor treatment (GroupA) 8NB
Morbidity and mortality from masses (GroupA)
Imaging to detect masses when intervention is effective (GroupA) 10NB
SEGA development (GroupA)
mTOR inhibitor treatment (GroupA) 8NB
Edited MONDO ID
2020/04/29
Released (Under revision)
1.1.1
LAM development in women (GroupA)
mTOR inhibitor treatment (GroupA) 8NB
Morbidity and mortality from masses (GroupA)
Imaging to detect masses when intervention is effective (GroupA) 10NB
SEGA development (GroupA)
mTOR inhibitor treatment (GroupA) 8NB
added MONDO IDs and created scoring groups
2020/04/16
Released
1.1.1
LAM development in women (GroupA)
mTOR inhibitor treatment (GroupA) 8NB
Morbidity and mortality from masses (GroupA)
Imaging to detect masses when intervention is effective (GroupA) 10NB
SEGA development (GroupA)
mTOR inhibitor treatment (GroupA) 8NB
added MONDO IDs and created scoring groups
2019/10/03
Released (Under revision)
1.1.0
LAM development in women
mTOR inhibitor treatment 8NB
Morbidity and mortality from masses
Imaging to detect masses when intervention is effective 10NB
SEGA development
mTOR inhibitor treatment 8NB
Internal system migration related to merging adult and pediatric contexts.
2019/04/04
Released
1.1.0
LAM development in women
mTOR inhibitor treatment 8NB
Morbidity and mortality from masses
Imaging to detect masses when intervention is effective 10NB
SEGA development
mTOR inhibitor treatment 8NB
Internal system migration related to merging adult and pediatric contexts.
2018/11/01
Released
1.0.1
LAM development in women
mTOR inhibitor treatment 8NB
Morbidity and mortality from masses
Imaging to detect masses when intervention is effective 10NB
SEGA development
mTOR inhibitor treatment 8NB
Internal system migration related to score text replacement from E to N
2017/11/01
Released
1.0.0
LAM development in women
mTOR inhibitor treatment 8EB
Morbidity and mortality from masses
Imaging to detect masses when intervention is effective 10EB
SEGA development
mTOR inhibitor treatment 8EB
¤ Powered by BCM's Genboree.